Nanoparticles for Detection and Treatment of Peripheral Arterial Disease
Source abstract
Abstract
Abstract Peripheral arterial disease (PAD) is defined as a slow, progressive disorder of the lower extremity arterial vessels characterized by chronic narrowing that often results in occlusion and is associated with loss of functional capacity. Although the PAD occurrence rate is increasing in the elderly population, outcomes with current treatment strategies are suboptimal. Hence, there is an urgent need to develop new technologies that overcome limitations of traditional modalities for PAD detection and therapy. In this Review, the application of nanotechnology as a tool that bridges the gap in PAD diagnosis and therapy is in focus. Several materials including synthetic, natural, biodegradable, and biocompatible materials are used to develop nanoparticles for PAD diagnostic and/or therapeutic applications. Moreover, various recent research approaches are being explored to diagnose PAD through multimodality imaging with different nanoplatforms. Further efforts include targeted delivery of various therapeutic agents using nanostructures as carriers to treat PAD. Last, but not least, despite being a fairly new field, researchers are exploring the use of nanotheranostics for PAD detection and therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Peripheral Artery Disease Management · Cerebrovascular and Carotid Artery Diseases · Protease and Inhibitor Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering University of Texas at Arlington Arlington TX 76010 USA
Joint Biomedical Engineering Program University of Texas Southwestern Dallas TX 75235 USA
Division of Cardiology University of Texas Southwestern Medical Center Dallas TX 75235 USA
Funding
National Heart, Lung, and Blood Institute
References (100+)
Show source-provided references
1. 10.1093/bmb/lds02710.1093/bmb/lds027 ↗
2. 10.1161/01.ATV.0000037100.44766.5B10.1161/01.ATV.0000037100.44766.5B ↗
3. 10.1001/jama.286.11.131710.1001/jama.286.11.1317 ↗
4. 10.1177/000331971246673010.1177/0003319712466730 ↗
5. 10.1016/j.jvs.2013.03.04410.1016/j.jvs.2013.03.044 ↗
6. 10.1161/CIRCIMAGING.114.00212310.1161/CIRCIMAGING.114.002123 ↗
7. 10.1016/j.jvs.2016.08.09410.1016/j.jvs.2016.08.094 ↗
8. 10.1161/CIRCINTERVENTIONS.110.95834810.1161/CIRCINTERVENTIONS.110.958348 ↗
9. 10.1186/1479-5876-9-16510.1186/1479-5876-9-165 ↗
10. 10.1161/CIRCINTERVENTIONS.112.96832110.1161/CIRCINTERVENTIONS.112.968321 ↗
11. Kathryn Vowden P. V. · Huntleigh Healthcare Ltd. · 2004 · 109 · 3
12. 10.1016/S0039-6109(16)42739-810.1016/S0039-6109(16)42739-8 ↗
13. 10.1159/00026785010.1159/000267850 ↗
14. 10.1016/j.jstrokecerebrovasdis.2010.11.01110.1016/j.jstrokecerebrovasdis.2010.11.011 ↗
15. 10.1002/clc.2092510.1002/clc.20925 ↗
16. 10.1016/S0828-282X(10)70467-010.1016/S0828-282X(10)70467-0 ↗
17. 10.1088/0143-0815/9/4/00310.1088/0143-0815/9/4/003 ↗
18. 10.1177/000331971142517510.1177/0003319711425175 ↗
19. 10.1177/000331971142309510.1177/0003319711423095 ↗
20. 10.1177/000331971038068110.1177/0003319710380681 ↗
21. 10.1007/s12265-013-9493-910.1007/s12265-013-9493-9 ↗
22. 10.1161/CIRCULATIONAHA.106.62139110.1161/CIRCULATIONAHA.106.621391 ↗
23. 10.1109/TUFFC.2009.112610.1109/TUFFC.2009.1126 ↗
24. Chen H. · Quant. Imaging Med. Surg. · 2013 · 3 · 298
25. Lu J. T. · Rev. Cardiovasc. Med. · 2004 · 5 · 189
26. 10.1111/j.1468-0009.2008.00536.x10.1111/j.1468-0009.2008.00536.x ↗
27. 10.1161/CIRCULATIONAHA.109.88188810.1161/CIRCULATIONAHA.109.881888 ↗
28. 10.1177/170853811771419710.1177/1708538117714197 ↗
29. Markel A. · Int. J. Angiol. · 2015 · 34 · 416
30. 10.1001/archinte.163.8.88410.1001/archinte.163.8.884 ↗
31. 10.1016/j.ejvs.2008.01.00710.1016/j.ejvs.2008.01.007 ↗
32. Lane D. A. · Cochrane Database Syst. Rev. · 2013 · CD003075
33. 10.1016/j.jvs.2010.08.06010.1016/j.jvs.2010.08.060 ↗
34. 10.1016/S0140-6736(02)09670-810.1016/S0140-6736(02)09670-8 ↗
35. 10.1016/S0254-6272(11)60050-210.1016/S0254-6272(11)60050-2 ↗
36. 10.7326/0003-4819-153-10-201011160-0000710.7326/0003-4819-153-10-201011160-00007 ↗
37. 10.1126/science.284.5411.14310.1126/science.284.5411.143 ↗
38. 10.1024/0301-1526/a00046410.1024/0301-1526/a000464 ↗
39. Payne M. M. · Tex. Heart Inst. J. · 2001 · 28 · 28
40. 10.1161/01.CIR.102.suppl_4.IV-8110.1161/01.CIR.102.suppl_4.IV-81 ↗
41. 10.1016/j.carrev.2012.08.01210.1016/j.carrev.2012.08.012 ↗
42. 10.1016/j.actbio.2008.11.01210.1016/j.actbio.2008.11.012 ↗
43. 10.1038/srep3717710.1038/srep37177 ↗
44. Gruntzig A. · Schweiz. Med. Wochenschr. · 1977 · 107 · 1588
45. 10.1111/j.1540-8183.2010.00567.x10.1111/j.1540-8183.2010.00567.x ↗
46. 10.1161/CIRCULATIONAHA.106.68220310.1161/CIRCULATIONAHA.106.682203 ↗
47. 10.12659/PJR.88924510.12659/PJR.889245 ↗
48. 10.1115/1.400232410.1115/1.4002324 ↗
49. 10.1101/gad.104740310.1101/gad.1047403 ↗
50. 10.1021/acs.chemrev.6b0007310.1021/acs.chemrev.6b00073 ↗
51. 10.1007/s12410-009-9002-310.1007/s12410-009-9002-3 ↗
52. 10.1002/smll.20070035110.1002/smll.200700351 ↗
53. 10.1161/ATVBAHA.108.16550610.1161/ATVBAHA.108.165506 ↗
54. 10.1016/j.jacc.2009.08.09010.1016/j.jacc.2009.08.090 ↗
55. 10.1002/jmri.1003010.1002/jmri.10030 ↗
56. 10.1016/S1357-2725(96)00155-010.1016/S1357-2725(96)00155-0 ↗
57. 10.1038/nm0598-62310.1038/nm0598-623 ↗
58. 10.1161/01.ATV.0000235724.11299.7610.1161/01.ATV.0000235724.11299.76 ↗
59. 10.1136/heartjnl-2017-31144710.1136/heartjnl-2017-311447 ↗
60. 10.1002/mrm.2001010.1002/mrm.20010 ↗
61. 10.1039/C4CS00345D10.1039/C4CS00345D ↗
62. 10.1007/s10439-013-0952-x10.1007/s10439-013-0952-x ↗
63. 10.1016/j.jcmg.2008.08.00910.1016/j.jcmg.2008.08.009 ↗
64. 10.1073/pnas.060628110410.1073/pnas.0606281104 ↗
65. 10.1002/wnan.124310.1002/wnan.1243 ↗
66. 10.1182/asheducation-2009.1.72010.1182/asheducation-2009.1.720 ↗
67. Li X. X. · Int. J. Nanomed. · 2013 · 8 · 1063
68. 10.1161/CIRCULATIONAHA.109.89180410.1161/CIRCULATIONAHA.109.891804 ↗
69. 10.1007/s12265-014-9590-410.1007/s12265-014-9590-4 ↗
70. 10.1016/j.jacc.2010.09.02310.1016/j.jacc.2010.09.023 ↗
71. 10.2147/IJN.S11832810.2147/IJN.S118328 ↗
72. 10.1016/j.neuro.2010.04.00310.1016/j.neuro.2010.04.003 ↗
73. 10.1007/s11926-008-0033-610.1007/s11926-008-0033-6 ↗
74. 10.1159/00033863110.1159/000338631 ↗
75. 10.1038/srep0342410.1038/srep03424 ↗
76. 10.1016/j.coche.2015.01.00310.1016/j.coche.2015.01.003 ↗
77. Chen X. · Quant. Imaging Med. Surg. · 2013 · 3 · 298
78. 10.1016/j.transproceed.2006.12.01910.1016/j.transproceed.2006.12.019 ↗
79. 10.1021/ml100284410.1021/ml1002844 ↗
80. 10.1016/j.drudis.2007.06.01210.1016/j.drudis.2007.06.012 ↗
81. 10.1021/nl500573d10.1021/nl500573d ↗
82. Ankri R. · Int. J. Nanomed. · 2015 · 10 · 4437
83. 10.1148/radiol.1009247310.1148/radiol.10092473 ↗
84. 10.1016/j.nano.2014.12.00610.1016/j.nano.2014.12.006 ↗
85. 10.1002/cmmi.155110.1002/cmmi.1551 ↗
86. 10.1016/j.foodchem.2013.12.08910.1016/j.foodchem.2013.12.089 ↗
87. 10.1364/AO.37.00278810.1364/AO.37.002788 ↗
88. 10.2147/IJN.S12421810.2147/IJN.S124218 ↗
89. Habara M. · J. Invasive Cardiol. · 2009 · 21 · 552
90. 10.2147/POR.S13243910.2147/POR.S132439 ↗
91. 10.1111/j.1540-8183.2010.00615.x10.1111/j.1540-8183.2010.00615.x ↗
92. 10.1093/eurheartj/ehq06610.1093/eurheartj/ehq066 ↗
93. 10.1111/ceo.1229910.1111/ceo.12299 ↗
94. 10.1002/jcb.1007710.1002/jcb.10077 ↗
95. 10.1021/nl802351p10.1021/nl802351p ↗
96. 10.1021/nl070610y10.1021/nl070610y ↗
97. 10.1161/CIRCULATIONAHA.107.74956410.1161/CIRCULATIONAHA.107.749564 ↗
98. Kim J. · J. Nucl. Med. · 2006 · 47 · 330
99. 10.1038/nrcardio.2009.20110.1038/nrcardio.2009.201 ↗
100. 10.2967/jnumed.113.13200110.2967/jnumed.113.132001 ↗